Background: Immune thrombocytopenic purpura is one of the causes of platelet deficiency. Although vaccinations, particularly MMR, have been reported as a potential temporal trigger, ITP following routine infant immunisation is very rare.
Case Summary: We describe the case of a previously healthy 2-month-old infant who was brought to the Emergency Department by his parents with complaints of a spreading non-blanching petechial rash and bruising, which started three days back, initially more prominent over the legs and later on spreading towards the chest. The baby was born at full term by spontaneous vaginal delivery requiring vacuum assistance and no bleeding and bruising were observed at the time of delivery and he didn’t require any admission at the time of birth. The baby on presentation was clinically well, was tolerating oral feeds, there was no history of fever, and no history of preceding viral illness; there was also no history of any trauma. Of note, the infant received his routine childhood vaccinations, including 6 in 1, PCV, Men B, and oral rotavirus 15 days ago. The mother also noted bruising and swelling at the Men B injection site.
Method: Upon arrival to the ED after a detailed history, blood tests were done, and initial investigations demonstrated isolated severe thrombocytopenia, with a platelet count of 6 × 10⁹/L, hemoglobin of 10.5 g/dL, and white blood cell count of 9.4 × 10⁹/L. Blood film showed thrombocytopenia with no evidence of platelet clumping noted. The initial film showed neutropenia with an absolute neutrophil count of 0.74 x 10⁹/L and occasional reactive lymphocytes. No blast cells were seen. Coagulation studies were also done and were normal. His cranial ultrasonography was also reported as normal. The extended respiratory viral panel was negative, Epstein–Barr virus, and cytomegalovirus testing were negative as well. The patient was then discussed with the paeds hematology team and a diagnosis of acute immune thrombocytopenia was made. Considering the really low platelet count, it was planned to give IVIG (intravenous immunoglobulin), and the infant received one dose of intravenous immunoglobulin (IVIG). The patient remained stable afterward, and repeat FBC (full blood count) showed an improving trend in the platelet count; as the platelet count started to improve, hematology advised discharging him and doing weekly platelet counts. Platelet counts improved to 68 × 10⁹/L two weeks after treatment and subsequently normalised to 508 × 10⁹/L at five months' follow-up. Routine immunisations were temporarily deferred until platelet recovery and were later resumed according to the national immunisation schedule. The family was also reassured that future measles, mumps and rubella (MMR) vaccination was not contraindicated.
Conclusion: This case highlights the importance of recognizing ITP in an otherwise well-appearing child who presents with bruising and petechiae with a blood film showing isolated thrombocytopenia. It is also important that we exclude other alternative causes and promptly treat ITP with IVIG after discussion with the hematology team. Also, close haematology follow-up resulted in complete platelet recovery and safe resumption of routine childhood immunisations.

